Pharmacological profile of zacopride and new quaternarized fluorobenzamide analogues on mammalian α7 nicotinic acetylcholine receptor.

[1]  M. Maze,et al.  Title Alpha-7 nicotinic acetylcholine receptor agonist treatment reduces neuroinflammation , oxidative stress , and brain injury in mice with ischemic stroke and bone fracture , 2022 .

[2]  J. Vercouillie,et al.  Design of α7 nicotinic acetylcholine receptor ligands in quinuclidine, tropane and quinazoline series. Chemistry, molecular modeling, radiochemistry, in vitro and in rats evaluations of a [(18)F] quinuclidine derivative. , 2014, European journal of medicinal chemistry.

[3]  H. Arias,et al.  Novel 2-(substituted benzyl)quinuclidines inhibit human α7 and α4β2 nicotinic receptors by different mechanisms. , 2013, The international journal of biochemistry & cell biology.

[4]  M. Nash,et al.  Neuregulin Upregulates Microglial α7 Nicotinic Acetylcholine Receptor Expression in Immortalized Cell Lines: Implications for Regulating Neuroinflammation , 2013, PloS one.

[5]  M. Oz,et al.  On the interaction of β-amyloid peptides and α7-nicotinic acetylcholine receptors in Alzheimer's disease. , 2013, Current Alzheimer research.

[6]  D. Kombo,et al.  Pharmacological properties and predicted binding mode of arylmethylene quinuclidine-like derivatives at the α3β4 nicotinic acetylcholine receptor (nAChR). , 2013, Bioorganic & medicinal chemistry letters.

[7]  S. Thany,et al.  A fluorinated quinuclidine benzamide named LMA 10203 acts as an agonist of insect nicotinic acetylcholine receptors. , 2012, Insect biochemistry and molecular biology.

[8]  K. Dineley,et al.  α7 nicotinic acetylcholine receptors in Alzheimer's disease: neuroprotective, neurotrophic or both? , 2012, Current drug targets.

[9]  Ji-min Cao,et al.  A Novel Discovery of IK1 Channel Agonist: Zacopride Selectively Enhances IK1 Current and Suppresses Triggered Arrhythmias in the Rat , 2012, Journal of cardiovascular pharmacology.

[10]  T. Wallace,et al.  Targeting the nicotinic alpha7 acetylcholine receptor to enhance cognition in disease. , 2011, Biochemical pharmacology.

[11]  H. Parri,et al.  Research update: Alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease. , 2011, Biochemical pharmacology.

[12]  Thomas J. Raub,et al.  Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an agonist of the alpha7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia: synthesis and structure--activity relationship. , 2006, Journal of medicinal chemistry.

[13]  L. Wallace,et al.  High affinity ligands for the alpha7 nicotinic receptor that show no cross-reactivity with the 5-HT3 receptor. , 2005, Bioorganic & medicinal chemistry letters.

[14]  E. Wong,et al.  Discovery and structure-activity relationship of quinuclidine benzamides as agonists of alpha7 nicotinic acetylcholine receptors. , 2005, Journal of medicinal chemistry.

[15]  J C Gordon,et al.  The 5-HT3 antagonist tropisetron (ICS 205-930) is a potent and selective alpha7 nicotinic receptor partial agonist. , 2001, Bioorganic & medicinal chemistry letters.

[16]  Agneta Nordberg,et al.  Neuronal nicotinic receptors in the human brain , 2000, Progress in Neurobiology.

[17]  J. Yakel,et al.  Nicotinic receptors in the brain: correlating physiology with function , 1999, Trends in Neurosciences.

[18]  E. Kawashima,et al.  Organization of the mouse 5-HT3 receptor gene and functional expression of two splice variants. , 1994, Brain research. Molecular brain research.

[19]  M. Langlois,et al.  Derivatives of quinuclidine as 5-HT3 receptor antagonists: influence of an additional carbonyl group on the recognition of chirality by the receptor. , 1993 .

[20]  R. Naylor,et al.  Zacopride, a potent 5‐HT3 antagonist , 1988, The Journal of pharmacy and pharmacology.